In May, a t Old man He was taken to Mount Sinai Hospital in Brooklyn to perform an operation. 'Blood test' was published I was fed with a new, fatal and poisonous bacterium.
This fungus, called a fungus called Candida auris, attacks those who have defenses, and delivers it quietly all over the world. T. Over the last five years, he hit a newborn unit in Venezuela, spreading through a hospital in Spain, led to the closure of a prestigious medical center in the UK for his CTI, and a root in India t , Pakistan and South Africa.
Recently, C. auris They arrived in New York, New Jersey and Illinois, arriving Centers for Control and Prevention of United States Illness (CDC, for an acronym in English) which contributed to the list of germs considered as "direct risks".
The old man died in hospital after 90 days of hospital admission, but there was no C. Auris. The trials were found in every part of his room, in an aggressive way that the hospital needed a special cleaning kit and that they had to remove part of the flag from the roof and the floor for removing it t .
"Everything was good – the walls, the bed, the doors, the curtains, the phones, the little house," said the Hospital's president, Dr. Walter Scott. Scott Laurin. “The widow, the blind, on top of the room, had certified everything in the room. "
C. auris is so expensive that it is cheap from the main antifungal drugs, which makes it a new example of one of the most difficult health risks in the world: a drug faced infection is being tackled.
For decades, public health experts warned that the inadequate use of antibiotics has reduced drug efficiency that improves life expectancy as a result of its ability to treat deadly bacterial diseases. Recently, however, there has also been a explosion of fungi which combat drugs, which add an extraordinary amount of wonder to a weakening column of modern medicine.
"It's a big problem," said Matthew Fisher, a professor in the fungal epidemiology of Imperial College London, a co-author of a recent scientific study into the conservation of protective fungi. “We rely on being able to deal with these patients with antifungals.”
Simple, fungi, such as bacteria, are developing defenses to sustain modern cures. A UK government-funded study counts, unless policies are put in place to combat the increase in drug production, in 2050 perhaps ten million people could die out across the UK. T these diseases, which would be higher than eight, are the result of these diseases. millions of people killed by cancer in that year. "
Antibiotics and antifungals are essential for the prevention of infection, but antibiotics are also used to stop diseases in farm animals, and antifungals are also banned for avoiding agricultural crops. Some scientists say evidence that using more fungicides in the past has contributed to the development of a drug-resistant fungus that affects people.
Although the problem is growing, little is known about the part of the population, partly because of the lack of convincing infection. Hospitals and local governments are being faced with the expression of diseases, bacteria and fungi, and an outbreak of an infectious disease.
C. auris is one of the twelve dangerous bacteria and fungi that have encountered hostility. But, like most of them, it is a threat to the majority of the population.
Other major problems of the fungus Candida – one of the most common causes of blood flow infections in hospitals – they have not tried to conquer drugs, but over 90% of diseases are caused by C. auris At least one drug, and 30% against two or more drugs, said the CPC.
Lynn Sosa, Deputy Director of Ecology in Connecticut, said that she is now seeing fungi as its main threat to disease. T "It is almost unbelievable and difficult to commemorate"ratified him.
Almost half of the patients who are contracted C. auris die within 90 days t, says the CDC. However, experts from around the world have not decided where it came from. "It seems that he has left the loch black," said Tom Chiller, the department's department specializing in fungi. "It came to somewhere and now it's everywhere."
Since the CPC is working to prevent the spread of drug-protective C. auris, the researchers have attempted to answer this question: what part of the world did it come from?
The first time doctors discovered C. auris in 2009, in Japan. Three years later, he appeared in Nijmegen, Holland, in an unusual result due to an analysis of blood disease in 18 patients from four hospitals in India. Soon after, new groups of C. auris arrived in different parts of the world each month.
When the CPC's researchers compared the total gene sample of auris samples from India, Pakistan, Venezuela, South Africa and Japan, they discovered that their origin was not from one place, and did not exist. there was just one kind of it. The order of genealogy revealed that there were four different versions of the fungus, with such variations, that it had spread these species to thousands. patterns which countered the environment in four different places at the same time.
"In some way, it jumped, it seems almost the same time, it spread, and is counter to drugs, which are very amazing," said Snigdha Vallabhanemi, an expert at the works. CDC.
Opinion is divided on the adventures of C. auris. and some link to fungi.
But of course the mystery of C. auris remains unresolved and at that time its foundation is less important to stop him.